Nutritional Interventions in Patients With Alcohol-associated Hepatitis

Status Not yet recruiting

Clinical Trial Summary

Alcohol-associated hepatitis (AH) is a life-threatening condition with high 90-days mortality (up to 40%) and limited treatment options. Previous studies have shown that decreased nutritional intake (less than 21 kcal/kg/day) is associated to a higher mortality compared to patients with a higher caloric intake. Additionally, it has been suggested that subjects with severe AH, should receive a high-protein diet, however, no specific trials have been carried out to address these questions. Thus, the investigators aim to compare nutritional interventions through a randomized controlled trial to assess if a strategy of peripheral parental nutrition (PPN) plus oral nutritional supplementation (ONS) improves outcomes in patients with severe AH. The investigators will compare standard oral intake, enhanced oral intake with IV fluid supplementation, and PPN plus ONS in patients admitted to hospital with severe AH. These results potentially will help guide practitioners on caloric benchmarks targets for patients with severe AH. This study will also assess specific risks and benefits of different nutritional interventions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06131177
Study type	Interventional
Source	Western University, Canada
Contact
Status	Not yet recruiting
Phase	N/A
Start date	January 1, 2025
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04066179` - Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Patients.	N/A
Completed	`NCT03732586` - Effect of Omega 5 Fatty Acid as an Adyuvant Treatment to Prednisone in Patients With Severe Alcoholic Hepatitis	N/A
Completed	`NCT01476995` - Prognostic Indicators as Provided by the EPIC ClearView	N/A
Completed	`NCT00962442` - N-Acetylcysteine in Severe Acute Alcoholic Hepatitis	Phase 3
Not yet recruiting	`NCT06307522` - MRG-001 in Patients With Alcoholic Hepatitis	Phase 2
Recruiting	`NCT05018481` - HA35 Moderate Alcoholic Hepatitis (AH) Study	Early Phase 1
Completed	`NCT04544020` - Changes in gUt micRobiota After Enteral Feeding (in Alcoholic Hepatitis)
Recruiting	`NCT04088370` - Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
Completed	`NCT04235855` - EUS Guided Liver Biopsy - Will it Give Better Yield, More Tissue With Less Complication?	N/A
Active, not recruiting	`NCT02344680` - Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Completed	`NCT00851981` - Randomized, Controlled Trial of S-adenosylmethionine in Alcoholic Liver Disease	Phase 2
Completed	`NCT04084522` - Effect of Saturated Fat (Desi Ghee) on Gut-Liver Axis in Alcoholic Hepatitis	N/A
Completed	`NCT05840640` - Granulocyte Colony Stimulating Factor Four Week Plus N-Acetyl Cysteine in Severe Alcoholic Hepatitis	Phase 4
Recruiting	`NCT03069300` - N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis	Phase 3
Terminated	`NCT02039219` - Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)	Phase 2
Completed	`NCT01245257` - Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic Hepatitis	N/A
Completed	`NCT02019056` - Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis	Phase 2
Completed	`NCT00388323` - Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human	N/A
Recruiting	`NCT03845205` - Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH	N/A
Recruiting	`NCT03703674` - GCSF in Alcoholic Hepatitis	Phase 4